SCHEMBL6680155

SCHEMBL6680155

COc1cccc(C2=CC(=Cc3cccc(C(=O)O)c3)CCC2CN(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.52
CCR6 P51684 1/20 0.52
VDR P11473 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.37
HSD17B2 P37059 2/20 0.36
MCHR1 Q99705 1/20 0.36
GSK3B P49841 1/20 0.36
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
BCHE P06276 1/20 0.35
MAOB P27338 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
FABP1 P07148 1/20 0.35
STIM1 Q13586 1/20 0.35
ORAI1 Q96D31 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677969 1.00 HSP90AA1 (0.52) HSP90AA1CCR6VDRMRGPRX4HSD17B2
SCHEMBL6680149 1.00 HSP90AA1 (0.52) HSP90AA1CCR6VDRMRGPRX4HSD17B2
Hydrochloric Acid SCHEMBL6716594 0.99 HSP90AA1 (0.53) HSP90AA1CCR6VDRMRGPRX4HSD17B2
Hydrochloric Acid SCHEMBL6716591 0.99 HSP90AA1 (0.53) HSP90AA1CCR6VDRMRGPRX4HSD17B2
Hydrochloric Acid SCHEMBL6724070 0.99 HSP90AA1 (0.53) HSP90AA1CCR6VDRMRGPRX4HSD17B2
SCHEMBL6683197 0.90 HSP90AA1 (0.49) HSP90AA1CCR6NPC1RAB9AMEN1
SCHEMBL6683199 0.90 HSP90AA1 (0.49) HSP90AA1CCR6NPC1RAB9AMEN1
SCHEMBL6677972 0.90 HSP90AA1 (0.48) HSP90AA1CCR6HSD17B2
SCHEMBL6722389 0.90 HSP90AA1 (0.48) HSP90AA1CCR6HSD17B2
SCHEMBL6677017 0.90 HSP90AA1 (0.48) HSP90AA1CCR6HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US claimed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US claimed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 HSP90AA1 1652/4885CCR6 1317/4885VDR 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.